Impact of stirred suspension bioreactor culture on the differentiation of murine embryonic stem cells into cardiomyocytes by Shafa, Mehdi et al.
RESEARCH ARTICLE Open Access
Impact of stirred suspension bioreactor culture
on the differentiation of murine embryonic stem
cells into cardiomyocytes
Mehdi Shafa
1, Roman Krawetz
2, Yuan Zhang
1, Jerome B Rattner
1,3, Anna Godollei
1, Henry J Duff
4 and
Derrick E Rancourt
1*
Abstract
Background: Embryonic stem cells (ESCs) can proliferate endlessly and are able to differentiate into all cell
lineages that make up the adult organism. Under particular in vitro culture conditions, ESCs can be expanded and
induced to differentiate into cardiomyocytes in stirred suspension bioreactors (SSBs). However, in using these
systems we must be cognizant of the mechanical forces acting upon the cells. The effect of mechanical forces and
shear stress on ESC pluripotency and differentiation has yet to be clarified. The purpose of this study was to
investigate the impact of the suspension culture environment on ESC pluripotency during cardiomyocyte
differentiation.
Results: Murine D3-MHC-neo
r ESCs formed embyroid bodies (EBs) and differentiated into cardiomyocytes over 25
days in static culture and suspension bioreactors. G418 (Geneticin) was used in both systems from day 10 to enrich
for cardiomyocytes by eliminating non-resistant, undifferentiated cells. Treatment of EBs with 1 mM ascorbic acid
and 0.5% dimethyl sulfoxide from day 3 markedly increased the number of beating EBs, which displayed
spontaneous and cadenced contractile beating on day 11 in the bioreactor. Our results showed that the bioreactor
differentiated cells displayed the characteristics of fully functional cardiomyocytes. Remarkably, however, our results
demonstrated that the bioreactor differentiated ESCs retained their ability to express pluripotency markers, to form
ESC-like colonies, and to generate teratomas upon transplantation, whereas the cells differentiated in adherent
culture lost these characteristics.
Conclusions: This study demonstrates that although cardiomyocyte differentiation can be achieved in stirred
suspension bioreactors, the addition of medium enhancers is not adequate to force complete differentiation as
fluid shear forces appear to maintain a subpopulation of cells in a transient pluripotent state. The development of
successful ESC differentiation protocols within suspension bioreactors demands a more complete understanding of
the impacts of shear forces on the regulation of pluripotency and differentiation in pluripotent stem cells.
Background
Embryonic stem cells (ESCs) are derived from the inner
cell mass (ICM) of pre-implantation embryos [1]. These
ESCs have the ability to remain undifferentiated and
proliferate indefinitely in vitro, while maintaining the
potential to differentiate into all three embryonic germ
layers [1,2]. An important aspect of ESC research
focuses on elucidating the mechanisms of differentiation
from the pluripotent ESC to various terminally differen-
tiated cell types. This differentiation capacity makes
ESCs an attractive cell source for cell/tissue replacement
therapies for the treatment of human degenerative dis-
eases. Moreover, ESCs can also be used as a model sys-
tem for understanding human genetic disease by
elucidating the pathophysiology of specific genetic disor-
ders, including but not limited to cardiac abnormalities.
The in vitro differentiation of ESCs into cardiomyo-
cytes provides an opportunity to study the developmen-
tal aspects of cardiomyogenesis. Cardiomyocytes are
terminally differentiated muscle cells in the adult
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small percentage of the cells may be capable of prolif-
eration [3], this is not sufficient for regeneration after
myocardial injury. The ultimate goal in cardiac regen-
erative medicine is to produce in large-scale, highly pur-
ified cardiomyocytes which are suitable for cell
transplantation. Such cell transplantation therapies
would require the successful seeding of as many as 1 ×
10
8 donor cardiomyocytes per patient [4].
From a commercial perspective, the ability to generate
such clinically relevant cell numbers through an eco-
nomically viable bioprocessi sap r i o r i t y .T h er o b u s t
generation of such large cardiomyocyte numbers could
only be feasible in controlled stirred suspension bioreac-
tors capable of maintaining high-density ESC numbers.
Currently, most protocols use static culture to differenti-
ate ESCs into cardiomyocytes [5-12]. Although routinely
used for ESC culture and differentiation, static culture
flasks can only support a pre-clinical research project.
Alternatively, stirred suspension bioreactors offer several
advantages over the conventional culture methods. We
and others have previously demonstrated that suspen-
sion bioreactors can support large-scale expansion of
the ESCs over extended passages, while retaining their
pluripotency [13,14].
The scalable production of ESC- derived cardiomyo-
cytes in a suspension bioreactor system has previously
been demonstrated using a retinoic acid based protocol
[ 1 5 , 1 6 ] .H o w e v e r ,s i n c ew eh a v ep r e v i o u s l yo b s e r v e d
that the suspension bioreactor environment enhances
ESC pluripotency, while suppressing differentiation effi-
ciency [17], we sought to investigate whether this phe-
nomenon would also occur in during cardiomyocyte
differentiation. This study demonstrates that suspension
bioreactor culture systems do indeed have the ability to
inhibit differentiation, and even induce ‘transient’ pluri-
potency within a defined differentiation protocol, pre-
sumably due to influence of shear stress on the cells.
Our data shows that in contrast to static culture, ESC
cultures induced to differentiate toward cardiomyocytes
in suspension bioreactors retain some ability to express
pluripotency markers, to form ESC-like colonies, and to
generate teratomas upon transplantation.
Results
Tumorigenicity of bioreactor-derived cardiomyocytes
The elegant study by Zandstra et al., demonstrated that
ESC-derived cardiomyocytes could indeed be generated
in a scalable stirred suspension bioreactor provided cells
were lineage selected [16]. However, based on our pre-
vious observation demonstrating increased tumorigen-
esis of ESC-derived chondrocytes and osteoblasts in
stirred suspension bioreactors, we were interested to
determine if this effect was eliminated within the G418
(Geneticin) selected population. Using D3-MHC-neo
r
ESCs from the Zandstra study, we induced cardiomyo-
cyte differentiation in static and suspension culture for
teratoma analysis. The resultant cardiomyocytes from
both bioreactor and static culture (with and without
G418 selection) were injected into severe combined
immunodeficiency (SCID) mice and after 21 days, were
harvested and processed for histopathology studies.
Interestingly, lineage selected cardiomyocytes from both
bioreactor and static differentiation cultures produced
no tumor growth in vivo suggesting that drug selection
for terminal markers may indeed be a reliable tool for
the scalable production of ESC derivatives. As expected,
static and bioreactor differentiated cells without drug
selection during differentiation produced teratomas;
however, tumors developed from bioreactor cultured
ESCs were significantly larger (~10 mm
2)t h a ns t a t i c
derived tumors (2-3 mm
2). Furthermore, teratomas
formed from bioreactor ESCs contained cells representa-
tive of all three germ layers; whereas, cells from static
culture did not. Only some gut-like epithelial cells were
recognizable within the teratoma derived from static
culture (Figure 1). Based on this result, we undertook
the characterization of cardiac bodies generated in the
bioreactor, in addition to an analysis of gene expression
during differentiation.
Expression of pluripotency markers and cardiac marker
before/after drug selection in suspension and static
culture condition
RT-PCR results confirmed the expression of cardiac
genes in addition to the expression of pluripotency mar-
kers during differentiation in the suspension culture
bioreactor. Cardiac markers were examined in non-drug
selected bioreactors. a-MHC (myosin heavy chain) gene
expression was up-regulated on day 6 through day 14 in
EBs and decreased gradually to the end of the differen-
tiation experiment. The early mesodermal marker
PCAM-1(Platelet endothelial cell adhesion molecule-
CD31) began to be expressed on day 3 and persisted
until day 21. Expression of other cardiogenesis lineage
genes such as ALCAM (activated leukocyte cell adhe-
sion molecule, CD166) and ANF (atrial natriuretic fac-
tor) showed that the ESCs successfully differentiated to
cardiomyocytes in the suspension bioreactor. Among
the examined pluripotency markers, Oct4 was consis-
tently expressed on all days during differentiation, sur-
prisingly, even with drug selection present from day 10
of the differentiation protocol. Sox2 expression was
absent after G418 selection, but was still expressed in
the bioreactor without lineage selection. Nanog expres-
sion in the non-drug selected bioreactor fluctuated dur-
ing the first 10 days of differentiation, with expression
being up-regulated at day 14 and decreasing gradually
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ture, Nanog expression was down-regulated on day 5
and the pluripotency markers Oct4 and Sox2 were com-
pletely absent on day10 after LIF removal (Figure 2B).
The cardiac marker a-MHC started to be expressed on
day 5 after LIF removal and persisted until the end of
experiment. Quantitative RT-PCR in the non-drug
selected bioreactors showed that Oct4, Sox2, and Nanog
expression persisted during differentiation in the bior-
eactor culture compared to static culture. The maxi-
mum fold increase in expression was on day 15 for
Sox2 and Nanog and day 20 for Oct4 (Figure 2C).
Since RT-PCR is a global gene expression assay, fluor-
escence-activated cell sorting (FACS) analysis was used
to confirm these marker results at the cellular and pro-
tein level in non-drug selected cells. FACS showed that
the pluripotency marker Oct4 was expressed during all
time points of differentiation examined (Figure 3A, C).
In the absence of LIF and G418 selection, the expression
of Oct4 positive cells increased from ~20% on day 10 to
~55% on day 25 in the bioreactor. Correspondingly,
expression of the cardiac marker, a-MHC (MF-20),
increased from ~6.5% on day 10 to ~20% by day 20
with a decrease to ~14% by day 25. Surprisingly, a small
population of cells (<10%) expressed both Oct4 and a-
MHC (validated with isotype controls) within bioreac-
tors without drug selection. These double positive cells
reached a plateau on day 15 during differentiation (Fig-
ure 3A). Confocal microscopy also was used to further
confirm and validate the existence of Oct4 and Nanog
positive cells (Figure 3B). Interestingly, bioreactor-differ-
entiated cells (without drug selection) retained their
ability to form ESC-like colonies on gelatin coated plates
after 25 days differentiation. However differentiated cells
in static culture lost this ability (Figure 4A). Confocal
microscopy also confirmed the simultaneous expression
of a-MHC and Oct4 in cells within the bioreactor-dif-
ferentiated EBs (Figure 4B).
Characterization of bioreactor-derived cardiomyocytes
With the observation that pluripotent cells persisted
through induced differentiation and the possibility of
‘bipotent’ Oct4+/a-MHC+ cells, it was next imperative
to characterize and test the functionality of the bioreac-
tor derived cardiomyocytes. Within the bioreactor, ESCs
aggregated one day after the initial inoculation of single
cells without LIF (Figure 5A), with aggregates increasing
in size during differentiation. The first beating EBs were
seen on day 12, after removal of the LIF and remained
for the rest of differentiation period (Figure 5B, Addi-
tional file 1). Moreover, the cardiac outgrowths of disso-
ciated aggregates kept beating for almost 45 days with
beating rates ranging from 29-60 beats/min. The maxi-
mum percentage of beating EBs (50%) was on day 14
after differentiation (Figure 5C). Conversely, the appear-
ance of the first beating EBs in the hanging drop
method was on day 6 of EBs, even before moving to
suspension culture.
After selection with G418, the resistant derived- cardi-
omyocytes in the bioreactor had the ultrastructure phe-
notype of differentiated cardiomyocytes as revealed by
light and electron microscope. Dissociated cells were
used for light microscope visualization, as well as immu-
nofluorescent staining. After dissociation; the cells pro-
duced clusters of spontaneously contractile areas, which
were positive for a-MHC as revealed by
Figure 1 Pluripotency of bioreactor differentiated cells as shown by tumor formation in SCID mice. A) The 125-mL NDS stirred-
suspension bioreactor. B) Sections of teratoma generated from non-drug selected pluripotent mESCs in bioreactor showing cells from all three
germ layers: (Star) Mesoderm; (Circle) Ectoderm; (Triangle) Endoderm (H&E staining). C) Teratoma derived from mESCs after differentiation under
static culture system. The majority of teratoma contains unorganized tissue. Only some gut-like epithelial cells were recognizable (Square).
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Light microscope showed rounded mononuclear cells
with definite subcellular compartments. Transmission
electron microscopy of whole cardiac bodies revealed
the presence of cardiomyocyte-specific ultrastructure
including myofibrils with distinct Z-, I-, H-and A-bands,
as well as cell-cell adhesion structures such as gap junc-
tions and desmosomes (Figure 5E).
Pharmacological responses of ESC-derived
cardiomyocytes
Spontaneously contracting cardiomyocytes were exam-
ined to check if they retain the ability to respond to
pharmacological agents. Upon administration of Isopre-
naline (b1-adrenergic receptor agonist), Phenylephrine
(a-adrenergic receptor agonist) and BayK8664 (Ca
2+
channel activator), the beating frequency of cardiac
bodies were enhanced. However, the chronotropical
effect of Diltiazem (Ca
2+ channel blocker) treatment was
negative on cardiomyocyte beating rate (Figure 6A). The
highest increased frequency was observed for BayK8664
which was reversed to the previous beating rate about
four hours after removal of the drug through changing
the media (Figure 6B). This highlights the existence of
developed functional Ca
2+ ion channels in cardiomyo-
cytes. These characterization experiments demonstrated
Figure 2 Expression of pluripotency and cardiac markers during differentiation in suspension culture. A) RT-PCR showed the expression
of pluripotency as well as cardiac lineage genes during differentiation in the suspension bioreactor. The G418 used from day 10 of
differentiation to select cardiomyocytes: w: with drug; w/o: without drug, Neg: Negative control. The numbers show days past differentiation.
Cardiac markers were examined in non-drug selected bioreactors. B) RT-PCR showed the absence of pluripotency markers gene expression
during static differentiation. The expression of the cardiac lineage gene a-MHC increased during differentiation in static culture in non-drug
selected cultures. C) Quantitative RT-PCR results in non-drug selected cultures revealed the fold increase of gene expression due to shear forces
in suspension bioreactor compared to static culture during the time course of cardic differentiation. Values represent means±SD of 3
independent experiments. p < 0.05.
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diac specific markers, but also displayed the properties
of functional cardiomyocytes.
Discussion
The large-scale production of differentiated cells suita-
ble for clinical transplantation is a fundamental objec-
tive of regenerative medicine research. The
replacement of damaged cells using in vitro differen-
tiated functional cardiomyocytes has received more
attention in the last decade with clinical trials on the
horizon. Despite many developments in the stem cell
field, we still lack the ability to produce adequate num-
ber of suitable differentiated cells that can meet clini-
cal requirements. We conducted this study to evaluate
the tumorgenicity of bioreactor derived cardiomyo-
cytes, since we have observed that ESCs differentiated
in stirred suspension culture maintain their
pluripotency compare to those differentiated in static
culture [17]. In this study we observed that by day 12
following the removal of LIF in suspension, ESCs
underwent efficient differentiation into cardiomyocytes
in the presence of ascorbic acid and DMSO. Expres-
sion of the early mesodermal marker (PCAM) and car-
diomyocyte specific markers (ALCAM (CD166) [18],
ANF [19], a-MHC and b-MHC [20]) clearly confirmed
the differentiation of ESCs into cardiomyocyte in stir-
red suspension culture. Similarly, in static culture, cells
efficiently made EBs three days after the removal of
LIF and the derived-cardiac bodies showed characteris-
tics of cardiomyocytes including expression of the
molecular marker a-MHC. It has previously been
shown that both AA and DMSO enhance differentia-
tion of mouse ESCs into cardiac myocytes. It has been
suggested that AA induces permissive changes
enabling cardiomyocyte differentiation, while DMSO
Figure 3 Expression of pluripotency and cardiac markers after 25 days in suspension culture. A) Fluorescence-activated cell sorting (FACS)
analysis of Oct4 and MF-20. The percentage of cells expressing Oct4 increased from 20% to 54%. The maximum percentage of cells expressing
MF-20 was on day 20 and declined afterward. A population of cells was expressing both markers at the same time during differentiation.
Statistical analysis (ANOVA) was performed using GraphPad Prism4 (GraphPad Software) and significance was set at p < 0.05. B) Confocal
microscopy confirmed the expression of Oct4 and Nanog in a sub-population of cells 20 days after differentiation in bioreactor. C) Distribution of
cell populations in suspension culture system as revealed by FACS analysis of Oct4 and MF-20 genes.
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scription factors, such as GATA-4 and Nkx-2.5. How-
ever, the exact related mechanism for triggering these
genes is still not very well known [21,22].
Ultra-structural studies by electron microscopy
revealed the specific subcellular sarcomeric organization
of cardiomyocytes, such as Z-banding. H- and A-bands,
and intercalated discs including desmosome and gap
junction were also obvious in derived cells. The chrono-
tropical responses of cardiomyocytes confirmed the exis-
tence of specialized Ca
+2 channels as well as a1 and b1-
adrenergic receptors.
Importantly, no tumors were generated after cardio-
myocyte lineage selection used to eliminate cells not
expressing the a-MHC-neo
r gene. Based on these
experiments, we assume that functional cardiomyocytes
had been produced that didn’t pose a risk of tumor for-
mation in vivo. However, it should be emphasized that
e v e ni nt h ep r e s e n c eo fd r u gs e l e c t i o n ,E S C sd i f f e r e n -
tiated in stirred suspension culture, still maintained the
expression of pluripotency markers. This trend was even
more apparent in cultures not undergoing drug selection
pressure, where a sub-population expressed both Oct4
and a-MHC simultaneously in the same cell. It is
important to remember, however, that drug selection
did negate tumor formation signifying that the expres-
sion of pluripotent genes is either: (i) not maintained
once the cells are taken out of expansion, or (ii) not suf-
ficient to reprogram a cell that has undergone terminal
differentiation.
Furthermore, the results presented here show that
even after differentiation toward cardiomyocytes, a sub-
population of cells (54%) still express Oct4 demonstrat-
ing some link between Oct4 gene expression and the
environment. This observation is further confirmed by
the difference observed in teratoma formation between
static and suspension. The suspension bioreactor differ-
entiations retained cell pluripotency to a degree that
ESCs formed teratomas representative of all three germ
layers. In contrast, cells from static cultures only formed
Figure 4 Pluripotency of bioreactor-differentiated embryoid bodies. A) Differentiated ESCs retained their ability to form ESC-like colonies
upon plating on gelatin-coated culture plates. The morphology of the colonies as well as expression of pluripotency markers showed the
pluripotency of differentiated cells after 25 days in suspension bioreactor without drug selection. Immunostaining was performed with
antibodies against Nanog and Oct4. B) Confocal microscopy of day 25 EBs showed the simultaneous expression of a-MHC and Oct4 within the
bioreactor-derived aggregates. Scale bar: 100 μm.
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tumor masses were still generated. While lineage selec-
tion using transgenic constructs is a useful research
tool, this approach cannot be applied clinically. Hence,
our observation that bioreactor-derived cardiomyocytes
maintain hallmarks of pluripotency has significant impli-
cations. Before the large scale production of cardiomyo-
cytes in suspension bioreactors will be possible, it will
be necessary to eliminate bioreactor induced
pluripotency.
We have recently evaluated the application of suspen-
sion bioreactor culture for the generation of cartilage
and bone tissue [17]. Unlike the static culture environ-
ment, bioreactor-differentiated aggregates caused tera-
toma formation when implanted subcutaneously into
SCID mice, which implicated the existence of pluripo-
tent cells in the bioreactor even after 30 days of suspen-
sion culture. Upon closer analysis of cells within
aggregates, we discovered that cells on the ridges of the
aggregate expressed the greatest amount of Oct4 in
Figure 5 Mouse ESC
neo differentiation in suspension culture. A) Murine ES cell aggregates. The size of EBs was growing over time period of
differentiation. B) Beating cardiac body (CB) 21 days after differentiation. The CBs were beating rhythmically with various rates. C) Percentage of
beating EBs. The maximum percentage of beating was 50% on day 14 of EBs. D) Dissociated cardiomyocytes stained with specific cardiac
antibody Myosin sarcomere (MF-20) green and DAPI-blue. E) Beating cardiac bodies showed specific subcellular ultrstructure of cardiomyocytes
using electron microscopy. The presence the cardiomyocytes specific structure including nucleus and myofibrils, mitochondria, Endoplasmic
reticulum, gap junctions and desmosomes was shown. Hb: H-band; Ib: I-Band; Ab: A-band; Zb: Z-band; Dj: Desmosome Junction; GJ: Gap
junction; Mi: Mitochondria; RE: Reticulum Endoplasmic; N: Nucleus. Scale bars: 100 μM.
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amount of laminar fluid flow. This result suggested that
the maintenance of pluripotency within bioreactor dif-
ferentiation cultures was the result of fluid shear stress.
In the current study, much like all our other bioreactor
studies, we apply an agitation rate of 100 rpm (shear
stress of 6.1 dyne/cm
2) in order to optimize mass trans-
fer and avoid necrosis, which otherwise occurs at lower
velocities [13].
We believe that liquid shear stress in the stirred sus-
pension bioreactor plays an important mechanistic role
in bioreactor induced pluripotency. Shear stress can
modulate gene expression through mechanotransduc-
tion, where physical signals are sensed at the cell per-
iphery, transduced into biochemical signals within the
cell, ultimately resulting in cell responses, including
changes in gene expression [23,24]. Previous studies in
other cells have demonstrated that shear stress can
induce the nuclear translocation of ß-catenin into the
nucleus [25,26]. As ß-catenin is an important regulator
of pluripotency [27], we are interested in the role of the
non-canonical Wnt signaling pathway in this induced
Figure 6 Chronotropical responses of bioreactor-derived cardiomyocytes. A) Variation in the number of beatings after drug application.
The highest change was due to application of Bay K8664. B) Changes in beating rate. The frequency of changes in beating clearly showed the
development of mature ion channels in the membrane of cardiomyocytes, which enabled them to respond to drugs (P < 0.05).
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(Lymphoid enhancer factor/T cell factor) reporter sys-
tem, we have confirmed that ß-catenin nuclear occu-
pancy is considerably increased over controls when cells
are exposed to 6.1 dynes/cm
2 shear stress compared to
lower levels of shear generated by lower velocities of
stirring (unpublished data). Following nuclear transloca-
tion, b-catenin forms a complex with LEF/TCF tran-
scription factors. This complex interacts with the
specific sequence in the promoter region to activate
transcription of certain genes.
Recently, Saha et al. has shown that biaxial cyclic
strain above a certain threshold inhibits human ESC dif-
ferentiation and enhances their self-renewal without
selecting against growth or survival of differentiated or
undifferentiated cells [28]. This group later suggested
that strain may induce autocrine or paracrine signaling
through TGF-b(Transforming growth factor-beta) super-
family ligands in human ESCs since the TGF-b super-
family activation of Smad2/3 was necessary for
suppression of spontaneous differentiation under strain
[29].
Despite the fact that stirred suspension cultures are
very useful for the generation of a large number of
undifferentiated cells, we have found that the addition
of medium enhancers is not adequate to force complete
differentiation of the popula t i o ni ns u s p e n s i o nb i o r e a c -
tors. By elucidating the exact mechanism(s) by which
liquid shear stress may contribute to promoting pluripo-
tency and preventing differentiation, we will be able to
create an efficient environment for both the production
of large quantities of pluripotent stem cells, and their
differentiated progeny. This is an important objective
for human regenerative medicine, as lineage selection
using transgenes will not be possible.
Conclusions
Although stirred suspension bioreactors are very
advantageous for the scalable generation of undifferen-
tiated cells, addition of medium enhancers is not suffi-
cient to induce complete differentiation. Our
observation that bioreactor-derived cardiomyocyte cul-
tures maintain characteristics of pluripotency has sig-
nificant implications for human regenerative medicine.
We believe that liquid shear stress in the stirred sus-
pension bioreactor plays an important mechanistic role
in bioreactor induced pluripotency, which needs
further investigation.
Methods
ESC culture
Murine D3-MHC-neo
r ESCs (a gift from Dr. Peter
Zandstra, University of Toronto) were maintained in
the pluripotent state on gelatin-coated tissue culture
dishes with inactivated mouse embryonic fibroblasts
(MEFs) in high glucose Dulbecco’s modified eagles
medium (DMEM; Invitrogen) supplemented with 15%
FBS (Invitrogen), 0.1 mM non-essential amino acids, 50
U/mL Streptomycin and 50 U/mL Penicillin, 0.1 mM b-
mercaptoethanol (Gibco), and 1000 U/mL Leukemia
Inhibitory Factor (LIF) (ESGRO, Chemicon). The cells
were sub-cultured every second day on MEF feeders.
Expansion of pluripotent ESCs in stirred suspension
bioreactors was carried out as previously described
[13,14].
Cardiomyocyte differentiation
Differentiation of D3-MHC-neo
r ESCs was performed in
a 125 ml suspension bioreactor (Corning Style Spinner
Flask, NDS Technologies Inc. Figure 1A) by seeding
about 5 × 10
4 cells/ml into ESC medium without LIF.
As an accepted procedure, removal of LIF triggers series
of events that cause the spontaneous differentiation of
mESCs. Formed embryoid bodies (EBs) were treated
with 1 mM ascorbic acid and 0.5% DMSO from day 3
to the end of the experiment to induce cardiomyocyte
differentiation. The culture media was changed every 4
days. An agitation rate of 100 rpm was used to achieve
the shear stress of 6.1 dyne/cm
2 in suspension as
described previously [13]. Differentiation on static cul-
ture was performed with hanging drop method. Briefly,
cell suspensions were diluted to 400-500 cells/20 μli n
differentiation medium. Each cell suspension was
pipetted onto the inner surface of the tissue culture
plate cover and cultured for 3 days. The suspended dro-
plets were transferred into a 100 mm bacteriological
plate with differentiation media and incubated for 5
days to form EBs and then plated on gelatin-coated 24-
well tissue culture plate for further differentiation. Both
ascorbic acid (1 mM) and DMSO (0.5%) were added to
induce cardiomyocyte differentiation from day 3 to the
end of the differentiation (Day 25). Each differentiation
procedure (static or bioreactor) were run as triplicate.
Similarly, all of the characterization experiments were
performed three times. As the cells carry the MHC-neo
r
transgene, the expression of the neomycin resistance
gene in ESC-derived cardiomyocytes enables their selec-
tion using G418 during in vitro differentiation. G418
(400 μg/ml) was added to the cultures from day 10 in
order to enrich for cardiomyocytes by eliminating non-
resistant, undifferentiated cells. In order to examine the
pluripotency of differentiated cells, derived-EBs from
suspension bioreactor (without drug selection) were dis-
sociated by trypsin for 5 min followed by plating on
gelatin-coated culture plates using mESC media with
LIF. Differentiated cells in static culture were also tryp-
sinized for 3 min and replated on gelatin-coated plates
using mESC media with LIF (above).
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CB-17 SCID mice were ordered from Taconic Company
and housed in the animal facility of the Faculty of Medi-
cine, University of Calgary. Animal protocols were per-
formed as approved by the University of Calgary Health
Science Animal Care Committee. Cells were harvested
from both bioreactor and static cultures after three
weeks of differentiation using Trypsin/EDTA. Four mice
were injected with differentiated cells of each group: 1)
bioreactor without G418 selection, 2) bioreactor with
G418 selection 3) static differentiation without selection
and 4) static differentiation with selection. 10
6 cells in a
total volume of 100 μl PBS were injected into the skin
fold of the each inner thigh. After 21 days, the animals
were sacrificed and tissues were dissected and examined
by histological procedures. In summary, 4% PFA was
used to fix the tissue overnight at 4°C. After dehydration
by increasing concentration of ethanol, the tissue was
embedded in paraffin. Sections were stained with H&E
a n de x a m i n e df o rd i f f e r e n tt y p e so ft i s s u e sb yl i g h t
microscopy.
Immunofluorescence
Aliquots of ESC aggregates, taken from the bioreactor at
various intervals from day 0 to day 25 of differentiation,
were washed with PBS, and fixed overnight in 4% PFA
in PBS at 4°C. Aggregates were then washed three times
with PBS, permeabilized in 0.5% saponin in PBS at 4°C
overnight, rinsed three times with PBS, then blocked in
3% BSA at 4°C overnight. The primary antibodies for
Nanog, Oct4 and a-MHC (Santa Cruz Biotechnology,
Inc. CA, USA) were diluted 1:50 in 3% BSA and added
to the aggregates (overnight at 4°C). Approximately 20-
25 aggregates were incubated in 50 μl of antibody solu-
tion. The aggregates were then washed 3 times with
PBS and blocked again overnight at 4°C. Following the
blocking step, the aggregates were incubated overnight
at 4°C with Alexa-fluor 488 secondary antibody and
TOTO-3 (Molecular Probes). TOTO-3, a carbocyanine
dimer stain with far-red fluorescence, was used as a
nuclear counterstain. After incubation, the aggregates
were washed 3 times with PBS and mounted on slides
with mountant (9:1 glycerol:PBS). Spacers (0.25 mm)
were attached to slides before mounting to avoid aggre-
gate deformation. Slides were analyzed by confocal
microscopy (Zeiss 510) using 488, 568 and 633 nm fil-
ters. To process the images, LSM image browsing soft-
ware was used.
For immunofluorescence staining of single cardiomyo-
cytes, EBs were dissociated with collagenase or accutase
for 15 min at 37°C. Mechanical dissociation of beating
areas was performed under a stereo dissecting micro-
scope using a 27G1/2 needle attached to a 1 ml pipette.
Dissociated cells were transferred to fresh media and
washed 2-3 times with Dulbecco’s Phosphate Buffered
Saline (DPBS) and incubated with trypsin for 5-7 min.
The cells were plated in 24-well gelatin-coated plates or
35 mm dish for 2 days and then stained with cardiac
specific antibody MF-20 (a-MHC).
Semi-quantitative and real-time PCR
RT-PCR was utilized to evaluate the expression of the
pluripotency and cardiac-specific transcripts. RNA was
isolated from derived aggregates at various stages of dif-
ferentiation in static (Day 0, 5, 10, 15, 20) and bioreactor
(Day 0, 5, 10, 15, 20 and 25) cultures. The RNeasy Mini
Kit (74106, Qiagen) was used to isolate RNA according
to the manufacturer’s instructions. The RNA concentra-
tion was measured by spectrophotometer (BioPhot-
ometer, Ependorf). 1 μg of total RNA was transcribed
into cDNA using an oligo dT primer and SuperScript
III cDNA synthesis Kit (18080-51, Invitrogen). PCR
amplification was carried out in a final volume of 20 μl
using Taq DNA polymerase (Invitrogen) using the fol-
lowing steps: 94°C for 3 min, 94°C for 30 sec, 55°C for
45 sec and 72°C for 1 min. Gene primer sets used in the
amplification reactions were designed and blasted
( N C B I )f o rm o u s eE S Cs p e c i ficity. Primer sequences
were listed in Table 1. GAPDH was used as an internal
standard. PCR products were separated on a 1.5% agar-
ose gel, stained with ethidium bromide, visualized and
photographed on a UV trans-illuminator.
For quantitative, real-time RT-PCR, standard curves
were derived from dilution of the amplicons. Real Time
RT-PCR was performed in an iCycler iQ system (Biorad)
using a SYBR green PCR master mix (Biorad). The fol-
lowing cycles were used: 3 min at 95°C as initial dena-
turation, followed by 30 sec at 95°C, 30 sec annealing at
57°C and 30 sec extension at 72°C for 45 cycles. Melting
curves were generated at the end of each run to ensure
the presence of a single amplicon. Expressions were nor-
malized to GAPDH, a housekeeping gene and compared
to static culture. Semi-quantitative and real-time PCR
were performed in triplicate.
Transmission electron microscopy (TEM)
Cells were pelleted, washed in PBS and fixed in 3%
glutaraldehyde in Millonig’s phosphate buffer for 1
hour at RT. Post-fixation was in 2% OsO4 for 20 min-
utes. The cells were dehydrated in ethanol, and then
embedded in Polybed 812 resin (Polysciences, War-
rington, PA). Polymerization was performed at 37°C
for 24 hours. Silver-gray sections were cut with an
ultramicrotome (Leica) equipped with a diamond knife,
stained with uranyl acetate and lead citrate, and then
examined in a H-7000 Hitachi electron microscope.
Fifteen separate samples from suspension bioreactor
were used for TEM.
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Beating cardiomyocytes outgrowths were investigated at
day 14 of differentiation (4 days after G418 selection).
The frequency of beating was calculated by the number
of cardiomyocyte pulsations per minute. The beating
rate was determined before and after application of each
drug. After the addition of drugs, the cardiac bodies
were incubated for 5 min before measurement. The var-
iation in beating was measured by the difference of the
pulsation rates between pre and post addition of each
drug. Twenty separate samples were tested for each
drug. The following drugs (all from Sigma) were used:
isopernaline (10
-3 M, 117H1382-5g), phenylephrine (10
-
3M, P-6126), Diltiazem (10
-3M, D2521-1g), and Bay
K8644 (10
-3 M, B-133).
Flow cytometry
At different time points of differentiation, EBs were har-
vested from the bioreactor and investigated for expres-
sion of pluripotency markers (Oct4, Nanog and Sox2)
and cardiac marker a-MHC by flow cytometry. Accu-
tase (eBioscience) treatment for 15 min followed by
pipetting was used to dissociate EBs to single cell. Dis-
persed cells were washed one time with PBS. The pellet
was resuspended in 1 ml of 4% paraformaldehyde (PFA)
in PBS then washed 3 × 5 min with 4 ml PBS. The cells
were permeabilized in 2 ml of 0.5% saponin for 15 min
at room temperature. They were washed once with 2 ml
PBS for 5 min and resuspended in 3%BSA/PBS for 30
min at 37°C. The primary antibody (approximately 1 μg
per 1 million cells) was conjugated with 5 μlo fC o m p A
(Invitrogen) and incubated 5 min at room temperature.
Then 5 μl of Comp B was added and incubated 5 min.
The conjugated primary antibody was then added to cell
suspension and incubated for 60 min at 37°C. The cells
were washed 3 times with PBS and resuspended in 200
μl FACs tubes. FACs experiments were performed using
a BD FACSVantage SE™ System at the University of
Calgary’s Flow Cytometry Facility.
Statistical analysis
Results were expressed as means±SD. Significance of
quantitative RT-PCR results and chronotropical
responses of derived cardiomyocytes was evaluated by
the Student’s t-test. Difference were considered statisti-
cally significant at values of P < 0.05. Statistical analysis
(ANOVA) was performed for the FACS results using
GraphPad Prism4 (GraphPad Software) and significance
was set at p < 0.05.
Additional material
Additional file 1: Beating of bioreactor-derived cardiac body. The
differentiation of mouse ESC into beating cardiac bodies was observed
using video microcopy. The first beating EBs were seen on day 12 after
LIF removal in stirred suspension bioreactor.
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